•
Mar 31, 2021
Harrow Q1 2021 Earnings Report
Announced record results for the first quarter ended March 31, 2021.
Key Takeaways
Harrow Health reported its best financial quarter in history for Q1 2021, with a 25% increase in product units distributed compared to the prior-year quarter and a 39% increase in commercial sales under the DEXYCU contract compared to Q4 2020.
The first quarter of 2021 was the best financial quarter in Harrow Health’s history.
Product units distributed during the first quarter increased 25% over the prior-year quarter.
Commercial sales under the DEXYCU contract increased 39% over the fourth quarter of 2020.
The company raised over $75 million to improve its capital base for acquisitions and future challenges.